Resources
Disruptive Innovation: What The Hell Is This?
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ As a matter of fact this is an updated version of my old post. An Up-to-dated Repost… Seventy years ago, when TV became widespread, pundits said it would replace all the other arts and media: books, newspapers, radio, theater, cinema, all of it. […]
We Will Be Speaking in Boston Soon
Igor Stefanov, Kingsman @ ACROSS and CEO @ Synergy will speak at the Clinically Validated Digital Therapeutics Summit 2018, Boston, 3-4 December. The Clinically Validated Digital Therapeutics Summit is the platform for pharma digital innovators, DTx trailblazers and healthcare pioneers to advance the translation, application and commercialization of evidence-based, robustly validated digital therapeutics. http://www.clinicallyvalidated-dtx.com/
We Will Speak at 7th International Forum “Clinical Trials in Russia”
Steven Bukvic, Chairman @ ACROSS and Chief Strategy Officer @ Synergy will deliver his speech on “Prevolution Within CRO Industry” at 7th International Forum “Clinical Trials in Russia”, Moscow, 13-14 November. http://www.clinical-trials-russia.com/
Blockchain in Clinical Trials: Tokens in Pharma
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ Let’s take a break from risks and take a look at another promising trend which is also in the area of Synergy’s particular interest, blockchain technology. Let’s talk about tokens… Firstly, to make sure we’re on the same page, I’d like to explain […]
Clinical Study Risk Assessment: How to Predict the Unpredictable?
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ I’m a system engineer by my first higher education. The diploma says “System Engineer in Design and Evaluation of Combat Aircraft”. For five years after graduation from university I was involved in top secret work on the optimization of all Russian combat aircrafts. […]
Clinical Trials in Russia Up 17%
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ The Ministry of Health of the Russian Federation approved the initiation of 184 new clinical trials of all types in Russia during Q3 2018, including local clinical trials (LCT) and bioequivalence (BE) studies with an overall year on year growth rate of 17% […]
Clinical Trials in Europe Down 23%
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ I’m pleased to introduce to you the European edition of our Orange Paper. Accrording to CT.GOV data, 6,396 new clinical trials of all types were started suring Q3 2018 worldwide. This comprises local and bioequivalence studies. There were 2,076 studies approved in USA […]
Meet SRG’s Orange Paper USA!
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ I’m pleased to introduce to you the new edition of our Orange Paper analysing clinical trials in the USA during Q3 2018. Meet the new USA member of SRG’s Orange Paper family! Worldwide Trials Up 19% According to ClinicalTrials.gov, 6,396 new clinical trials […]
Clinical Study Risk Visualization: Seeing is Believing
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ The sun rises soon after the rooster crows. What is the rooster in this case? Is the rooster a source of risk or just a key risk indicator? Is there a risk that sun will not rise, once the rooster doesn’t crow? With […]